EconPapers    
Economics at your fingertips  
 

Details about Johann Matthias Graf von der Schulenburg

E-mail:
Phone:+491633988889
Postal address:Schleiermacherstrasse 24 30625 Hannover Germany
Workplace:Wirtschaftswissenschaftliche Fakultät (School of Economics and Management), Leibniz Universität Hannover (University of Hannover), (more information at EDIRC)

Access statistics for papers by Johann Matthias Graf von der Schulenburg.

Last updated 2020-03-30. Update your information in the RePEc Author Service.

Short-id: pgr520


Jump to Journal Articles Edited books Editor

Working Papers

2015

  1. Cost of poor adherence to anti-hypertensive therapy in five European countries
    Post-Print, HAL View citations (2)

2014

  1. Grundlagen und Methoden von GKV-Routinedatenstudien
    Hannover Economic Papers (HEP), Leibniz Universität Hannover, Wirtschaftswissenschaftliche Fakultät Downloads View citations (1)

2013

  1. Cost of Poor Adherence to Anti-Hypertensive Therapy in Europe
    CEIS Research Paper, Tor Vergata University, CEIS Downloads

Journal Articles

2019

  1. Correction to: An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies
    The Geneva Papers on Risk and Insurance - Issues and Practice, 2019, 44, (2), 357-358 Downloads

2018

  1. German Value Set for the EQ-5D-5L
    PharmacoEconomics, 2018, 36, (6), 663-674 Downloads View citations (2)
  2. “Market withdrawals” of medicines in Germany after AMNOG: a comparison of HTA ratings and clinical guideline recommendations
    Health Economics Review, 2018, 8, (1), 1-11 Downloads

2017

  1. An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies
    The Geneva Papers on Risk and Insurance - Issues and Practice, 2017, 42, (4), 633-656 Downloads

2016

  1. Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany
    Applied Health Economics and Health Policy, 2016, 14, (4), 441-452 Downloads
  2. Benefit assessment in Germany: implications for price discounts
    Health Economics Review, 2016, 6, (1), 1-12 Downloads View citations (2)
  3. Measuring patients’ priorities using the Analytic Hierarchy Process in comparison with Best-Worst-Scaling and rating cards: methodological aspects and ranking tasks
    Health Economics Review, 2016, 6, (1), 1-11 Downloads View citations (1)
  4. Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe
    The European Journal of Health Economics, 2016, 17, (1), 79-87 Downloads View citations (3)

2015

  1. Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosis -
    Health Economics Review, 2015, 5, (1), 1-9 Downloads
  2. Rare is frequent and frequent is costly: rare diseases as a challenge for health care systems
    The European Journal of Health Economics, 2015, 16, (2), 113-118 Downloads
  3. Regional differences in health care of patients with inflammatory bowel disease in Germany
    Health Economics Review, 2015, 5, (1), 1-11 Downloads

2014

  1. Entwicklung der Leistungsempfängerzahlen in der Gesetzlichen Pflegeversicherung - Zum Einfluss unterschiedlicher Morbiditätsannahmen auf die Entwicklung der sozialrechtlich anerkannten Pflegebedürftigkeit in Deutschland
    Schmollers Jahrbuch : Journal of Applied Social Science Studies / Zeitschrift für Wirtschafts- und Sozialwissenschaften, 2014, 134, (2), 209-236 Downloads

2013

  1. Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system
    Health Economics Review, 2013, 3, (1), 1-17 Downloads

2012

  1. Corporate Management of Highly Dynamic Risks: Evidence from the Demand for Terrorism Insurance in Germany
    The Geneva Risk and Insurance Review, 2012, 37, (1), 57-82 Downloads View citations (1)
  2. Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study
    Health Policy, 2012, 108, (1), 19-26 Downloads View citations (3)
  3. Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany
    Health Economics Review, 2012, 2, (1), 1-13 Downloads

2011

  1. Greetings from the Editors
    Health Economics Review, 2011, 1, (1), 1-2 Downloads
  2. Letter from the editors
    The European Journal of Health Economics, 2011, 12, (1), 1-1 Downloads
  3. Measuring economic consequences of preterm birth - Methodological recommendations for the evaluation of personal burden on children and their caregivers
    Health Economics Review, 2011, 1, (1), 1-10 Downloads View citations (1)
  4. Promoting vaccinations - an analysis of measures taken by German statutory health insurers
    Health Economics Review, 2011, 1, (1), 1-6 Downloads

2010

  1. Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer
    The European Journal of Health Economics, 2010, 10, (1), 21-26 Downloads
  2. EJHE has an official impact factor of 1.337
    The European Journal of Health Economics, 2010, 11, (5), 435-435 Downloads
  3. Impact of the Introduction of the Social Long-Term Care Insurance in Germany on Financial Security Assessment in Case of Long-Term Care Need&ast
    The Geneva Papers on Risk and Insurance - Issues and Practice, 2010, 35, (4), 626-643 Downloads View citations (6)
  4. On the Impact of the Financial Crisis on the Dividend Policy of the European Insurance Industry
    The Geneva Papers on Risk and Insurance - Issues and Practice, 2010, 35, (1), 53-62 Downloads View citations (3)

2009

  1. Reinsurance Brokers and Advice Quality: Is There a Need for Regulation&quest
    The Geneva Risk and Insurance Review, 2009, 34, (1), 20-46 Downloads View citations (2)

2007

  1. Editor’s note
    The European Journal of Health Economics, 2007, 8, (3), 179-179 Downloads
  2. Nach welchen ökonomischen Methoden sollten Gesundheitsleistungen in Deutschland evaluiert werden? / According to Which Economic Methods Should Health Care Services Become Evaluated in Germany?
    Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik), 2007, 227, (5-6), 787-806 Downloads

2005

  1. Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany
    The European Journal of Health Economics, 2005, 6, (4), 317-321 Downloads View citations (1)
  2. German health care system in transition
    The European Journal of Health Economics, 2005, 6, (2), 183-187 Downloads View citations (2)
  3. Validating the EQ-5D with time trade off for the German population
    The European Journal of Health Economics, 2005, 6, (2), 124-130 Downloads View citations (15)

2002

  1. Commentary
    The European Journal of Health Economics, 2002, 3, (2), 138-138 Downloads View citations (3)
  2. Diffusion of innovations: treatment of Alzheimer's disease in Germany
    Health Policy, 2002, 60, (1), 59-66 Downloads

1993

  1. Bonus options in health insurance by Peter Zweifel. Awer Academic Publishers, Dordrecht, 1992. No. of ges: xii + 141. ISBN 0‐7923‐1722‐X
    Health Economics, 1993, 2, (1), 81-82 Downloads

1991

  1. Reliability of Risk Management: Market Insurance, Self-Insurance and Self-Protection Reconsidered
    The Geneva Risk and Insurance Review, 1991, 16, (1), 45-58 Downloads View citations (10)

1987

  1. Voting on Social Security: The Family as Decision‐Making Unit
    Kyklos, 1987, 40, (4), 529-547 Downloads

Edited books

2014

  1. Operations Research Proceedings 2012
    Operations Research Proceedings, Springer View citations (2)

Editor

  1. Health Economics Review
    Springer
 
Page updated 2020-07-07